- Home
- SMXT vs IMRX Comparison
SMXT vs IMRX Comparison
Compare SMXT & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMXT
- IMRX
- Stock Information
- Founded
- SMXT 2008
- IMRX 2008
- Country
- SMXT United States
- IMRX United States
- Employees
- SMXT N/A
- IMRX N/A
- Industry
- SMXT
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- SMXT
- IMRX Health Care
- Exchange
- SMXT NYSE
- IMRX Nasdaq
- Market Cap
- SMXT 58.9M
- IMRX 62.7M
- IPO Year
- SMXT 2024
- IMRX 2021
- Fundamental
- Price
- SMXT $1.13
- IMRX $1.14
- Analyst Decision
- SMXT
- IMRX Strong Buy
- Analyst Count
- SMXT 0
- IMRX 3
- Target Price
- SMXT N/A
- IMRX $15.33
- AVG Volume (30 Days)
- SMXT 96.5K
- IMRX 173.2K
- Earning Date
- SMXT 05-19-2025
- IMRX 05-05-2025
- Dividend Yield
- SMXT N/A
- IMRX N/A
- EPS Growth
- SMXT N/A
- IMRX N/A
- EPS
- SMXT N/A
- IMRX N/A
- Revenue
- SMXT $22,986,881.00
- IMRX N/A
- Revenue This Year
- SMXT N/A
- IMRX N/A
- Revenue Next Year
- SMXT N/A
- IMRX N/A
- P/E Ratio
- SMXT N/A
- IMRX N/A
- Revenue Growth
- SMXT N/A
- IMRX N/A
- 52 Week Low
- SMXT $0.60
- IMRX $1.00
- 52 Week High
- SMXT $13.48
- IMRX $3.83
- Technical
- Relative Strength Index (RSI)
- SMXT N/A
- IMRX 37.54
- Support Level
- SMXT N/A
- IMRX $1.10
- Resistance Level
- SMXT N/A
- IMRX $1.30
- Average True Range (ATR)
- SMXT 0.00
- IMRX 0.10
- MACD
- SMXT 0.00
- IMRX -0.01
- Stochastic Oscillator
- SMXT 0.00
- IMRX 9.76
About SMXT SOLARMAX TECHNOLOGY INC
SolarMax Technology Inc is an integrated solar and renewable energy company. It operates in two segments namely the United States and China. The United States business includes the sale and installation of photovoltaic and battery backup systems. China operations consist of operating and maintaining solar farm projects and identifying and procuring solar farm projects for resale to third parties. Some of its products are LG Solar Panels, QCELL Solar Panels, Panasonic Solar Panels, and others. The company generates a majority of its revenue from the Solar energy systems.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.